These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluconazole-cyclosporine interaction: a dose-dependent effect? López-Gil JA Ann Pharmacother; 1993 Apr; 27(4):427-30. PubMed ID: 8477116 [TBL] [Abstract][Full Text] [Related]
4. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group. Keown P; Landsberg D; Halloran P; Shoker A; Rush D; Jeffery J; Russell D; Stiller C; Muirhead N; Cole E; Paul L; Zaltzman J; Loertscher R; Daloze P; Dandavino R; Boucher A; Handa P; Lawen J; Belitsky P; Parfrey P Transplantation; 1996 Dec; 62(12):1744-52. PubMed ID: 8990355 [TBL] [Abstract][Full Text] [Related]
5. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation. Canadian Neoral Renal Transplantation Study Group Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295 [TBL] [Abstract][Full Text] [Related]
14. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin. Lang J; Finaz de Villaine J; Garraffo R; Touraine JL Am J Med; 1989 Nov; 87(5A):82S-85S. PubMed ID: 2589391 [TBL] [Abstract][Full Text] [Related]
16. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients. Romero AJ; Le Pogamp P; Nilsson LG; Wood N Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine. Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C; Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. First MR; Schroeder TJ; Alexander JW; Stephens GW; Weiskittel P; Myre SA; Pesce AJ Transplantation; 1991 Feb; 51(2):365-70. PubMed ID: 1994529 [TBL] [Abstract][Full Text] [Related]
19. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients. Kennedy MS; Yee GC; Mcguire TR; Leonard TM; Crowley JJ; Deeg HJ Transplantation; 1985 Sep; 40(3):249-53. PubMed ID: 3898489 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group. Barone G; Chang CT; Choc MG; Klein JB; Marsh CL; Meligeni JA; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL Transplantation; 1996 Mar; 61(6):875-80. PubMed ID: 8623152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]